Humana Inc. (NYSE:HUM) Shares Purchased by Sumitomo Mitsui DS Asset Management Company Ltd

by · The Cerbat Gem

Sumitomo Mitsui DS Asset Management Company Ltd raised its stake in Humana Inc. (NYSE:HUM – Free Report) by 1.9% in the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 13,955 shares of the insurance provider’s stock after acquiring an additional 256 shares during the period. Sumitomo Mitsui DS Asset Management Company Ltd’s holdings in Humana were worth $3,692,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently bought and sold shares of the company. LFA Lugano Financial Advisors SA raised its holdings in shares of Humana by 56.3% in the fourth quarter. LFA Lugano Financial Advisors SA now owns 125 shares of the insurance provider’s stock valued at $32,000 after buying an additional 45 shares during the last quarter. OFI Invest Asset Management acquired a new stake in Humana during the fourth quarter worth approximately $33,000. Riverview Trust Co acquired a new position in shares of Humana in the 1st quarter valued at $34,000. Garde Capital Inc. acquired a new position in shares of Humana during the 1st quarter valued at $36,000. Finally, Transce3nd LLC acquired a new stake in shares of Humana in the fourth quarter valued at about $38,000. Institutional investors and hedge funds own 92.38% of the company’s stock.

Analyst Ratings Changes

Several equities research analysts have recently weighed in on HUM shares. Robert W. Baird boosted their target price on shares of Humana from $270.00 to $300.00 and gave the stock a “neutral” rating in a research report on Tuesday, April 15th. Cantor Fitzgerald restated a “neutral” rating and set a $290.00 price target on shares of Humana in a research report on Thursday, May 1st. Guggenheim initiated coverage on shares of Humana in a research report on Wednesday, April 9th. They set a “buy” rating and a $326.00 price target on the stock. Barclays set a $268.00 target price on shares of Humana and gave the company an “equal weight” rating in a research note on Thursday, June 12th. Finally, Oppenheimer boosted their price target on shares of Humana from $300.00 to $310.00 and gave the company an “outperform” rating in a report on Thursday, May 1st. Sixteen research analysts have rated the stock with a hold rating and eight have issued a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and an average price target of $280.76.

Check Out Our Latest Analysis on Humana

Humana Price Performance

Shares of NYSE:HUM opened at $238.58 on Friday. The stock has a market cap of $28.79 billion, a PE ratio of 16.87, a price-to-earnings-growth ratio of 1.84 and a beta of 0.44. Humana Inc. has a 1-year low of $212.45 and a 1-year high of $406.46. The company has a current ratio of 1.91, a quick ratio of 1.91 and a debt-to-equity ratio of 0.71. The stock’s fifty day simple moving average is $240.79 and its two-hundred day simple moving average is $258.69.

Humana (NYSE:HUM – Get Free Report) last posted its quarterly earnings data on Wednesday, April 30th. The insurance provider reported $11.58 earnings per share for the quarter, topping the consensus estimate of $10.07 by $1.51. Humana had a net margin of 1.42% and a return on equity of 14.47%. The company had revenue of $32.11 billion for the quarter, compared to analysts’ expectations of $32 billion. During the same period in the prior year, the business earned $7.23 earnings per share. Humana’s revenue for the quarter was up 8.4% compared to the same quarter last year. As a group, analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, July 25th. Investors of record on Friday, June 27th will be paid a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.48%. The ex-dividend date of this dividend is Friday, June 27th. Humana’s payout ratio is 25.04%.

Humana Profile

(Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Recommended Stories

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).